Fast-growing Plavix Could Become Japan’s No. 1 Ethical Drug by Next Year

Sanofi K.K.’s top-selling product, the anti-platelet agent Plavix (clopidogrel sulfate), continues to make steady advances. With the approval of a series of new indications and guidelines for the management of cerebral stroke recommending Plavix, sales are growing, and the company...read more